Financials
- Market Capitalization 24.9 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
14.44
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 491 | INSM Insmed Incorporated - Common Stock | 121.82 USD | +2.77% | -3.11% | +24.05% | -24.83% | 26.60 B USD | ||
| 511 | ROIV Roivant Sciences Ltd. - Common Shares | 34.40 USD | -0.69% | -6.16% | +3.68% | +87.88% | 24.85 B USD | ||
| 524 | BNTX BioNTech SE - American Depositary Shares | 101.31 USD | -0.30% | -11.92% | +11.32% | +1.32% | 24.31 B USD | ||
| 569 | UTHR United Therapeutics Corporation - Common Stock | 514.38 USD | +0.78% | -0.61% | -0.37% | +22.51% | 22.06 B USD |